GSK’s Exdensur is approved by the US FDA as a twice-yearly add-on treatment for severe eosinophilic asthma in patients 12 and ...

The board of directors of Simris Group AB (publ) (“Simris Group” or the “Company”) has today resolved on a directed issue of units consisting of one (1) class B share and two (2) warrants of series ...

First CTA authorization marks nChroma’s transition to a clinical-stage company; first patient dosing in Phase 1/2 trial planned for early 2026 Preclinical studies demonstrated CRMA-1001 delivers ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that its therapeutic research arm, Caris Discovery, ...

Lund, Sweden, 16 December 2025. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that GOOD-IDES-02, a global pivotal Phase 3 trial in anti-glomerular basement membrane (anti-GBM) ...

On 27 July 2025, the board of directors of Simris Group AB (publ) ("Simris Group" or the "Company") resolved, by virtue of the authorisation granted by the annual general meeting held on 28 May 2025, ...

PALO ALTO, CALIFORNIA / ACCESS Newswire / December 17, 2025 / Bioz, Inc., the leading AI-powered platform that transforms published scientific data into actionable product insights, is pleased to ...

The Global 3D Cell Culture Market is poised for strong double-digit growth by 2027, driven by rapid advancements in biotechnology, growing interest in advanced disease models, and a rising need for ...

Generative AI in healthcare refers to advanced algorithms capable of generating new, original medical data or insights by learning patterns from existing datasets. These systems utilize deep learning ...

OverviewThe global bone void fillers (BVFs) market is poised to grow steadily at a CAGR of around 5% over the next five years, driven by the rising prevalence of orthopedic disorders, increasing ...

Dental CAD/CAM Market OverviewThe global dental CAD/CAM market is experiencing steady expansion and is projected to register a high single-digit growth rate through 2027.This growth reflects the ...

First-in-human trial of candidate from the next-generation ATTC platform —— Simultaneous China and global clinical development strategy to expedite development process —Hong Kong, Shanghai & Florham ...